Alison Woodcock, M Charlton and Clare Bradley (2007) Extent of satisfaction with tablets and food-timing in sulphonylurea-treated diabetes. Diabetes Research and Clinical Practice, 78 (3).
Full text access: Open
This study measured patient views about following tablet-taking and food-timing recommendations in Type 2 diabetes. Two new questionnaires were validated. Outpatients with Type 2 diabetes treated with sulphonylurea agents (n = 131) completed the seven-item Diabetes Tablet Treatment Questionnaire (DTTQ) and nine-item Diabetes Food Timing Questionnaire (DFTQ). Mean glycosylated haemoglobin (HbA1c) was 7.8% (S.D. 1.8%). At least 74% had optimal DTTQ item scores for tablet-taking as recommended, difficulty taking tablets, side effects, perceived hypoglycaemia and willingness to continue current tablets, but 71% scored sub-optimally regarding recent hyperglycaemia. Under half scored optimally on DFTQ items concerning eating at recommended times, difficulty with food-timing, denying oneself food and guilt about eating. Principal components and reliability analyses identified a two-item tablet problem scale within the DTTQ (α 0.72) and a seven-item food-timing problem scale in the DFTQ (α 0.77). Satisfaction and adherence were not closely related to glycaemic control. Only scores for perceived hyperglycaemia (r = 0.38), perceived hypoglycaemia (r = −0.24) and satisfaction to continue current tablets (r = −0.20) correlated significantly with HbA1c. Clinicians found that the DTTQ helped to raise tablet-taking issues otherwise missed in consultations. Both questionnaires can be used to guide the need for focussed discussion, educational intervention and/or treatment change and to evaluate their impact
This is a Published version This version's date is: 12/2007 This item is peer reviewed
https://repository.royalholloway.ac.uk/items/d0cf5a59-2884-599d-46b9-b9488a09ee92/1/
Deposited by () on 23-Dec-2009 in Royal Holloway Research Online.Last modified on 12-May-2010
The study was funded by a research grant from Aventis Pharma.
[1] British Medical Association and Royal Pharmaceutical Society of Great Britain, British National Formulary 45, March 2003, British Medical Association and Royal Pharmaceutical Society of Great Britain, London, 2003, pp. 335–339. [2] UK Prospective Diabetes Study Group, Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33), The Lancet 352 (1998), pp. 837–853. [3] B.S. Bloom, Daily regimen and compliance with treatment: fewer daily doses and drugs with fewer side effects improve compliance, Br. Med. J. 323 (2001), p. 647. Full Text via CrossRef | View Record in Scopus | Cited By in Scopus (39) [4] R. Gadsby and M. MacKinnon, Steps to better compliance in diabetic patients, Practitioner 243 (February (1595)) (1999), p. 103 106, 108. View Record in Scopus | Cited By in Scopus (1) [5] C. Bradley and K.S. Lewis, Measures of psychological well-being and treatment satisfaction developed from the responses of people with tablet-treated diabetes, Diab. Med. 7 (1990), pp. 445–451. View Record in Scopus | Cited By in Scopus (100) [6] C. Bradley, The Diabetes Treatment Satisfaction Questionnaire (DTSQ). In: C. Bradley, Editor, Handbook of Psychology and Diabetes: A Guide to Psychological Measurement in Diabetes Research and Practice, Harwood Academic, Chur, Switzerland (1994), pp. 111–132. [7] C. Bradley and J. Speight, Patient perceptions of diabetes and diabetes therapy: assessing quality of life, Diab. Metab. Res. Rev. 18 (2002), pp. S64–S69. Full Text via CrossRef | View Record in Scopus | Cited By in Scopus (41) [8] C. Bradley, C. Todd, T. Gorton, L. Symonds, A. Martin and R. Plowright, The development of an individualised questionnaire measure of perceived impact of diabetes on quality of life: the ADDQoL, Qual. Life Res. 8 (1999), pp. 79–91. Full Text via CrossRef | View Record in Scopus | Cited By in Scopus (74) [9] A.J. Woodcock, S. Julious, A.L. Kinmonth and M.J. Campbell, Problems with performance of the SF-36 amongst people with Type 2 diabetes in general practice, Qual. Life Res. 10 (2001), pp. 661–670. Full Text via CrossRef | View Record in Scopus | Cited By in Scopus (23) [10] DAFNE Study Group, Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: dose adjustment for normal eating (DAFNE) randomised controlled trial, Br. Med. J. 325 (2002), pp. 746–749. [11] Diabetes UK, Eating well: eight steps to healthy eating. http://www.diabetes.org.uk/eatwell/meal_planning/eightsteps.htm, 2003 (accessed 7 September 2004). [12] M.J. Franz, J.P. Bantle, C.A. Beebe, J.D. Brunzell, J.L. Chiasson and A. Garg et al., American Diabetes Association, Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications, Diab. Care 25 (2002), pp. 148–198. Full Text via CrossRef | View Record in Scopus | Cited By in Scopus (170) [13] The Diabetes Care and Complications Trial Research Group, The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus, N. Engl. J. Med. 329 (1993), pp. 977–986. [14] S. Manley, W.G. John and S. Marshall, Introduction of IFCC reference method for calibration of HbA1c: implications for clinical care, Diab. Med. 21 (2004), pp. 673–676. Full Text via CrossRef | View Record in Scopus | Cited By in Scopus (12) [15] A.J. Woodcock and C. Bradley, Validation of the HIV Treatment Satisfaction Questionnaire, Qual. Life Res. 10 (2001), pp. 517–531. Full Text via CrossRef | View Record in Scopus | Cited By in Scopus (18) [16] K.M. Loewenthal, An Introduction to Psychological Tests and Scales, UCL Press Limited, London (1996). [17] R. Plowright, E. Witthaus and C. Bradley, Psychometric evaluation of Diabetes Treatment Satisfaction Questionnaire in eight languages, Proc. Br. Psych. Soc. 8 (2000), p. 43.